http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107823188-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72d18102281030861bd40c200fc79f71 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-54 |
| filingDate | 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_696fe9c18977ba78a5a2e58d90b4364c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215c092e77e7ebc480a0553c9ff3cdbf |
| publicationDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107823188-A |
| titleOfInvention | A kind of compound flavone sustained-release capsule and preparation method thereof |
| abstract | The invention discloses a compound flavone sustained-release capsule and a preparation method thereof. The inclusion compound is prepared by using the method of β-cyclodextrin eagle tea flavone inclusion compound sustained-release capsule, and the β-cyclodextrin is made into a saturated aqueous solution, and then Gradually add hot water solution of eagle tea flavonoid extract, dry under reduced pressure and vacuum, and crush the solid to obtain clathrate; prepare sustained-release granules: put ethyl cellulose, hydroxypropylmethyl cellulose and the clathrate prepared in Mix in a dry container, add ethanol solution, stir until solid state, dry, pulverize to obtain granules. The invention increases the water solubility of the flavonoids in the eagle tea, improves the relative bioavailability of the flavones in the eagle tea to human body, and improves the health-care effect timeliness. Compared with the prior art, the sustained-release compound flavonoid capsules of the present invention have obvious hypoglycemic effect after a period of time, and can control the blood sugar level and related risk factors of diabetic patients, thereby improving the quality of life of diabetic patients. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115038340-A |
| priorityDate | 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.